Evidence map›Paper›PMID 35204514›Full record

ArticleDiagnostics (Basel, Switzerland)2022

Quantification and Classification of Contrast Enhanced Ultrasound Breast Cancer Data: A Preliminary Study.

Georgios S Ioannidis, Michalis Goumenakis, Ioannis Stefanis, Apostolos Karantanas, Kostas Marias

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Georgios S IoannidisComputational BioMedicine Laboratory (CBML), Foundation for Research and Technology-Hellas (FORTH), 70013 Heraklion, Greece.ORCID 0000-0002-8139-5790
Michalis GoumenakisComputational BioMedicine Laboratory (CBML), Foundation for Research and Technology-Hellas (FORTH), 70013 Heraklion, Greece.ORCID 0000-0001-6001-7865
Ioannis StefanisComputational BioMedicine Laboratory (CBML), Foundation for Research and Technology-Hellas (FORTH), 70013 Heraklion, Greece.
Apostolos KarantanasComputational BioMedicine Laboratory (CBML), Foundation for Research and Technology-Hellas (FORTH), 70013 Heraklion, Greece.
Kostas MariasComputational BioMedicine Laboratory (CBML), Foundation for Research and Technology-Hellas (FORTH), 70013 Heraklion, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to investigate which of the two frequently adopted perfusion models better describes the contrast enhanced ultrasound (CEUS) perfusion signal in order to produce meaningful imaging markers with the goal of developing a machine-learning model that can classify perfusion curves as benign or malignant in breast cancer data. Twenty-five patients with high suspicion of breast cancer were analyzed with exponentially modified Gaussian (EMG) and gamma variate functions (GVF). The adjusted R

Indexed as

breast carcinomacontrast enhanced ultrasonographyperfusion/modelsprognostic factorsquantitative analysis

Identifiers

PMID35204514
PMCPMC8871488

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.